It is now well-accepted that in addition to their key roles in nutrient metabolism and absorption, that intestinal commensal microorganisms are critically involved in programming intestinal CD4+ and CD8+ T cells to effectively perform their protective functions, including their roles in anti-tumor immunity, an issue which appears to impact on the efficacy of ICI-targeted immunotherapy. Here, CD4 is linked to neoplasm.